Clinical Trial Update: Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa [NA]

View source ↗

Summary

A clinical trial is comparing vaginal progesterone to 17-alpha-hydroxyprogesterone caproate for placenta previa, with the trial status currently listed as unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placenta Previa

Drugs mentioned

• Makena (hydroxyprogesterone caproate)
• Vaginal progesterone (progesterone)

Snippet

Sponsor: Aswan University Hospital | Conditions: Placenta Previa | NA | Status: UNKNOWN